XCures
It uses AI to clean and structure messy medical records, helping healthcare organizations turn fragmented clinical data into usable information.
Overview
XCures builds AI software for cleaning up messy medical records, converting fragmented healthcare documentation into more organized clinical data. The company targets healthcare organizations dealing with inconsistent, unstructured or hard-to-use patient records. Its differentiation centers on applying AI to one of healthcare’s persistent data quality problems: making medical records usable at scale. XCures raised a $46 million Series B in June 2026, bringing disclosed funding to $46 million across one round.
Funding History
Exclusive: XCures Lands $46M Series B To Clean Up Messy Medical Records With AI
Frequently Asked Questions
- How much funding does AI Funding track for XCures?
- AI Funding tracks $46M for XCures across 1 funding round in this database.
- Who are XCures's investors?
- XCures's investors include Innovius Capital, iGrow, Spring Mountain Capital.
- What does XCures do?
- XCures builds AI software for cleaning up messy medical records, converting fragmented healthcare documentation into more organized clinical data. The company targets healthcare organizations dealing with inconsistent, unstructured or hard-to-use patient records. Its differentiation centers on applying AI to one of healthcare’s persistent data quality problems: making medical records usable at scale. XCures raised a $46 million Series B in June 2026, bringing disclosed funding to $46 million across one round.
- Where is XCures headquartered?
- XCures is headquartered in Oakland, United States.
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.